top of page

Supply issue: Imiquimod (Padagis) cream 5% sachets

  • 2 hours ago
  • 1 min read

We are writing to inform you of a supply issue: Imiquimod (Padagis) cream 5% sachets.


Key messages:


  • The supplier of Imiquimod (Padagis) cream 5% sachets has notified that due to the conflict in the Middle East this product will be in short supply.

  • Pharmac has sourced and listed (funded) Aldara cream 5% sachets as an alternate. The Aldara brand has the same active ingredient.

  • This is not a Medsafe approved product and will need to be prescribed and dispensed in line with Section 29A of the Medicines Act.

  • Aldara cream 5% sachets are expected to be available from the third week of April.

  • A Recare prompt will be in place to remind prescribers that the Aldara brand - a Section 29A alternative is available.

 

For more information:


Please share this information with your colleagues and within your networks.


Questions:


If you have any queries, please reply to this email

If you no longer wish to receive emails from the Pharmac Implementation Team, please send a reply email with UNSUBSCRIBE in the subject heading. Thank you.

 

Ngā mihi,

 

Anna I Senior Advisor Implementation

Pharmac | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington

P: 0800 660 050 | www.pharmac.govt.nz



bottom of page